AnnieUmbrichtMD
Internal Medicine • Baltimore, MDAddiction Medicine
Assistant Professor, Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine
Dr. Umbricht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5510 Nathan Shock Drive
Behavioral Pharmacology Research Unit
Baltimore, MD 21224Phone+1 410-550-1917Fax+1 410-550-1924
Education & Training
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1986 - 1987
University of Lausanne Faculty of MedicineClass of 1980
Certifications & Licensure
MD State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Clinical Trial of Topiramate for Cocaine Addiction Start of enrollment: 2007 Feb 01
- Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse Start of enrollment: 2010 Jun 01
- Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 946 citationsPsilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards
Journal of Psychopharmacology. 2016-11-30 - 102 citationsMethadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.Kenzie L. Preston, Annie Umbricht, David H. Epstein
Archives of General Psychiatry. 2000-04-01 - 120 citationsImprovement in naltrexone treatment compliance with contingency management.Kenzie L. Preston, Kenneth Silverman, Annie Umbricht, Anna DeJesus, Ivan D. Montoya
Drug and Alcohol Dependence. 1999-04-01
Press Mentions
- Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderNovember 4th, 2020
Double-Blind Comparison of the Two Hallucinogens Psilocybin and Dextromethorphan: Effects on CognitionJuly 30th, 2018
FDA Approves Implant to Battle Opioid AddictionMay 27th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
